Literature DB >> 25299915

Development of the clinical next-generation sequencing industry in a shifting policy climate.

Margaret A Curnutte1, Karen L Frumovitz1, Juli M Bollinger2, Amy L McGuire1, David J Kaufman2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25299915      PMCID： PMC5125294          DOI： 10.1038/nbt.3030

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Next-generation sequencing for clinical diagnostics.

Authors:  Howard J Jacob
Journal:  N Engl J Med       Date:  2013-10-02       Impact factor: 91.245

2.  First FDA authorization for next-generation sequencer.

Authors:  Francis S Collins; Margaret A Hamburg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

3.  Realizing the opportunities of genomics in health care.

Authors:  Geoffrey S Ginsburg
Journal:  JAMA       Date:  2013-04-10       Impact factor: 56.272

Review 4.  Molecular genetic testing and the future of clinical genomics.

Authors:  Sara Huston Katsanis; Nicholas Katsanis
Journal:  Nat Rev Genet       Date:  2013-06       Impact factor: 53.242

5.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders.

Authors:  Yaping Yang; Donna M Muzny; Jeffrey G Reid; Matthew N Bainbridge; Alecia Willis; Patricia A Ward; Alicia Braxton; Joke Beuten; Fan Xia; Zhiyv Niu; Matthew Hardison; Richard Person; Mir Reza Bekheirnia; Magalie S Leduc; Amelia Kirby; Peter Pham; Jennifer Scull; Min Wang; Yan Ding; Sharon E Plon; James R Lupski; Arthur L Beaudet; Richard A Gibbs; Christine M Eng
Journal:  N Engl J Med       Date:  2013-10-02       Impact factor: 91.245

Review 6.  Informatics and clinical genome sequencing: opening the black box.

Authors:  Sowmiya Moorthie; Alison Hall; Caroline F Wright
Journal:  Genet Med       Date:  2012-09-13       Impact factor: 8.822

7.  Regulatory changes raise troubling questions for genomic testing.

Authors:  Barbara J Evans; Michael O Dorschner; Wylie Burke; Gail P Jarvik
Journal:  Genet Med       Date:  2014-09-25       Impact factor: 8.822
  7 in total
  18 in total

1.  The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project.

Authors:  Kathryn Maxson Jones; Rachel A Ankeny; Robert Cook-Deegan
Journal:  J Hist Biol       Date:  2018-12       Impact factor: 1.326

2.  Health Care Infrastructure for Financially Sustainable Clinical Genomics.

Authors:  Jochen K Lennerz; Heather M McLaughlin; Jason M Baron; David Rasmussen; Meini Sumbada Shin; Nancy Berners-Lee; Julie Miller Batten; Kathryn J Swoboda; Manish K Gala; Harland S Winter; Jeremy D Schmahmann; David A Sweetser; Marianne Boswell; Maciej Pacula; Albrecht Stenzinger; Long P Le; William Hynes; Heidi L Rehm; Anne Klibanski; Stephen W Black-Schaffer; Jeffrey A Golden; David N Louis; Scott T Weiss; A John Iafrate
Journal:  J Mol Diagn       Date:  2016-07-25       Impact factor: 5.568

3.  Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions.

Authors:  Fook Yee Cheung; Lauren Clatch; Susan M Wolf; Ellen Wright Clayton; Frances Lawrenz
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

4.  Developing context-specific next-generation sequencing policy.

Authors:  Margaret Ann Curnutte; Karen L Frumovitz; Juli M Bollinger; Robert M Cook-Deegan; Amy L McGuire; Mary A Majumder
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

5.  Clinical integration of next generation sequencing: a policy analysis.

Authors:  David Kaufman; Margaret Curnutte; Amy L McGuire
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

Review 6.  Sharing Data to Build a Medical Information Commons: From Bermuda to the Global Alliance.

Authors:  Robert Cook-Deegan; Rachel A Ankeny; Kathryn Maxson Jones
Journal:  Annu Rev Genomics Hum Genet       Date:  2017-04-17       Impact factor: 8.929

7.  The Limits of FDA's Authority to Regulate Clinical Research Involving High-Throughput DNA Sequencing.

Authors:  Barbara J Evans
Journal:  Food Drug Law J       Date:  2015       Impact factor: 0.619

8.  Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.

Authors:  Laurie E Steffen; Ruofei Du; Amanda Gammon; Jeanne S Mandelblatt; Wendy K Kohlmann; Ji-Hyun Lee; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Belinda Vicuña; Marc D Schwartz; Anita Y Kinney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-09-29       Impact factor: 4.254

9.  Availability and payer coverage of BRCA1/2 tests and gene panels.

Authors:  Elizabeth Clain; Julia R Trosman; Michael P Douglas; Christine B Weldon; Kathryn A Phillips
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

10.  Persistent confusion and controversy surrounding gene patents.

Authors:  Christi J Guerrini; Mary A Majumder; Amy L McGuire
Journal:  Nat Biotechnol       Date:  2016-02       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.